Projects per year
Search results
-
Active
i4MDS: Immune-monitoring of Myelodysplastic Neoplasms: recommendations from the i4MDS Consortium
Kordasti, S. (Primary Investigator) & Van Hemelrijck, M. (Co-Investigator)
EHA European Hematology Association
1/12/2024 → 30/11/2026
Project: Research
-
Guy's Cancer: Guy's Cancer Real World Evidence: An opportunity for Cardio-Oncology
Van Hemelrijck, M. (Primary Investigator)
4/10/2024 → 1/11/2025
Project: Research
-
-
Building an Advanced Therapies database to improve patient care and fuel pioneering research (RWE)
Van Hemelrijck, M. (Primary Investigator)
4/03/2024 → 3/03/2026
Project: Research
-
THRIVE - Implementation of a digital excercise intervention to promote and sustain excercise behaviour in prostate cancer patients on androgen deprivation therapy to improve outcomes
Van Hemelrijck, M. (Primary Investigator)
1/02/2024 → 31/01/2028
Project: Research
-
-
EMBED
Van Hemelrijck, M. (Primary Investigator)
EORTC European Organisation for Research and Treatment of Cancer
1/01/2024 → 31/12/2027
Project: Research
-
Facilitating the representation of EORTC QoL Modules and items in common data models
Van Hemelrijck, M. (Primary Investigator)
EORTC European Organisation for Research and Treatment of Cancer
1/04/2023 → 31/12/2025
Project: Research
-
Patient organization versus hospital-based recruitment strategies for EORTC QLG studies.
Van Hemelrijck, M. (Primary Investigator)
EORTC European Organisation for Research and Treatment of Cancer
1/08/2022 → 31/03/2027
Project: Research
-
Addressing the supportive care needs of men with testicular cancer by improving the patient reported outcome measures (PROMs) available to them.
Van Hemelrijck, M. (Primary Investigator)
1/07/2022 → 31/12/2025
Project: Research
-
BC-Recon: Diagnosing Bladder Cancer - Evaluating the Role of a Urinary Biomarker Test in the Reconfiguration of Haematuria Clinic Investigations (BC-Recon)
Van Hemelrijck, M. (Primary Investigator) & Sasieni, P. (Co-Investigator)
1/05/2022 → 30/04/2026
Project: Research
-
TRACERx Rena: TRAcking Renal Cell Carcinoma Evolution Through Therapy (Rx)
Van Hemelrijck, M. (Primary Investigator)
7/02/2022 → 11/09/2025
Project: Research
-
A phase 1-2 study to identify which HRQoL issues need to be assessed for cancer patients on immune checkpoint inhibitors
Van Hemelrijck, M. (Primary Investigator)
EORTC European Organisation for Research and Treatment of Cancer
7/06/2021 → 31/12/2025
Project: Research
-
-